Des-Ac-Nal-Ganirelix - Request Quote
Des-Ac-Nal-Ganirelix
| SZ CAT No: | SZ-G029013 |
| CAS No | NA |
| Mol.F. | C78H111ClN18O12 |
| Mol.Wt. | 1528.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Des-Ac-Nal-Ganirelix is chemically (S)-N-((R)-1-Amino-1-oxopropan-2-yl)-1-(N2-N2-((R)-2-((R)-2-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-3-(4-chlorophenyl)propanamido)-3-(pyridin-3-yl)propanoyl)-L-seryl-L-tyrosyl-N6-(bis(ethylamino)methylene)-D-lysyl-L-leucyl-N6-(bis(ethylamino)methylene)-L-lysyl)pyrrolidine-2-carboxamide. Des-Ac-Nal-Ganirelix is supplied with detailed characterization data compliant with regulatory guideline. Des-Ac-Nal-Ganirelix can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ganirelix.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Des-Ac-Nal-Ganirelix
Purchase Des-Ac-Nal-Ganirelix
Des-Ac-Nal-Ganirelix suppliers
Des-Ac-Nal-Ganirelix manufacturers
Des-Ac-Nal-Ganirelix price
Order Des-Ac-Nal-Ganirelix
Enquire Des-Ac-Nal-Ganirelix
Des-Ac-Nal-Ganirelix cost
Des-Ac-Nal-Ganirelix Supplier
Des-Ac-Nal-Ganirelix Distributor
Des-Ac-Nal-Ganirelix for Method Validation
Ganirelix Reference Standard
Des-Ac-Nal-Ganirelix for ANDA Filing
Des-Ac-Nal-Ganirelix for Forced Degradation Studies
Des-Ac-Nal-Ganirelix Identification Standards
Des-Ac-Nal-Ganirelix for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


